Bio-Techne to Present at Upcoming Investor Conferences

Bio-Techne (NASDAQ: TECH) will present at two investor conferences in early March 2026: TD Cowen 46th Annual Health Care Conference on March 3, 2026 at 11:10 AM EST and Leerink Partners Global Healthcare Conference on March 10, 2026 at 8:40 AM EDT.

Rhea-AI Summary

Bio-Techne (NASDAQ: TECH) will present at two investor conferences in early March 2026: TD Cowen 46th Annual Health Care Conference on March 3, 2026 at 11:10 AM EST and Leerink Partners Global Healthcare Conference on March 10, 2026 at 8:40 AM EDT. A live webcast will be available via the company's IR Calendar page.

Argus Feb 24 session

+5.19% close to close 1.2x rel. volume Open Argus

Details

News Market Reaction – TECH

On Feb 24, the day this news came out, TECH closed 5.19% above the previous close.

Data tracked by StockTitan Argus for the Feb 24 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MINNEAPOLIS, Feb. 24, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences:

TD Cowen 46^th Annual Health Care Conference
March 3, 2026
11:10 AM EST

Leerink Partners Global Healthcare Conference
March 10, 2026
8:40 AM EDT

A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.

About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated over $1.2 billion in net sales in fiscal 2025 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the Company on social media at: LinkedIn, X or YouTube.

Contact:	David Clair, Vice President, Investor Relations
	david.clair@bio-techne.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-upcoming-investor-conferences-302694785.html

SOURCE Bio-Techne Corporation

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Bio-Techne (TECH) present at the TD Cowen conference in 2026?

Bio-Techne will present at the TD Cowen conference on March 3, 2026 at 11:10 AM EST. According to the company, the presentation is scheduled as part of the TD Cowen 46th Annual Health Care Conference lineup and will be webcast live via the IR Calendar.

What are the date and time for Bio-Techne (TECH) at the Leerink Partners Global Healthcare Conference?

Bio-Techne is scheduled to present on March 10, 2026 at 8:40 AM EDT at the Leerink Partners Global Healthcare Conference. According to the company, investors can watch a live webcast accessible from the company's IR Calendar page.

How can investors watch Bio-Techne (TECH) presentations on March 3 and March 10, 2026?

Investors can access a live webcast of both presentations via Bio-Techne's IR Calendar page. According to the company, the webcast links will be available on the investor relations website at the IR Calendar URL provided.

Which investor conferences will Bio-Techne (TECH) attend in early March 2026?

Bio-Techne will present at the TD Cowen 46th Annual Health Care Conference and the Leerink Partners Global Healthcare Conference. According to the company, both presentations occur in early March 2026 and will be webcast live via the IR Calendar.